GSK new HIV two-drug injection meets main goal in late-stage study

British drugmaker GlaxoSmithKline Plc said on Thursday its long-lasting two-drug regimen to treat HIV met the main goal of a late-stage study.

from Reuters: Health News https://ift.tt/31Z4viz
via IFTTT